BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17264163)

  • 1. The Toll-like receptor 7/8-ligand resiquimod (R-848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet-activating factor biosynthesis.
    Hattermann K; Picard S; Borgeat M; Leclerc P; Pouliot M; Borgeat P
    FASEB J; 2007 May; 21(7):1575-85. PubMed ID: 17264163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
    Jurk M; Kritzler A; Schulte B; Tluk S; Schetter C; Krieg AM; Vollmer J
    Eur J Immunol; 2006 Jul; 36(7):1815-26. PubMed ID: 16783850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial toll-like receptor agonists induce sequential NF-κB-mediated leukotriene B4 and prostaglandin E2 production in chicken heterophils.
    Kogut MH; He H; Genovese KJ
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):159-70. PubMed ID: 22119018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective and direct activation of human neutrophils but not eosinophils by Toll-like receptor 8.
    Janke M; Poth J; Wimmenauer V; Giese T; Coch C; Barchet W; Schlee M; Hartmann G
    J Allergy Clin Immunol; 2009 May; 123(5):1026-33. PubMed ID: 19361845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human granulocyte-macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis.
    DiPersio JF; Billing P; Williams R; Gasson JC
    J Immunol; 1988 Jun; 140(12):4315-22. PubMed ID: 2453577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD14+ cells are required for IL-12 response in bovine blood mononuclear cells activated with Toll-like receptor (TLR) 7 and TLR8 ligands.
    Buza J; Benjamin P; Zhu J; Wilson HL; Lipford G; Krieg AM; Babiuk LA; Mutwiri GK
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):273-82. PubMed ID: 18789542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.
    Lan T; Kandimalla ER; Yu D; Bhagat L; Li Y; Wang D; Zhu F; Tang JX; Putta MR; Cong Y; Trombino AF; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13750-5. PubMed ID: 17698957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily.
    Heil F; Ahmad-Nejad P; Hemmi H; Hochrein H; Ampenberger F; Gellert T; Dietrich H; Lipford G; Takeda K; Akira S; Wagner H; Bauer S
    Eur J Immunol; 2003 Nov; 33(11):2987-97. PubMed ID: 14579267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor ligands induce polymorphonuclear leukocyte migration: key roles for leukotriene B4 and platelet-activating factor.
    Lefebvre JS; Marleau S; Milot V; Lévesque T; Picard S; Flamand N; Borgeat P
    FASEB J; 2010 Feb; 24(2):637-47. PubMed ID: 19843712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells.
    Hurst J; Prinz N; Lorenz M; Bauer S; Chapman J; Lackner KJ; von Landenberg P
    Immunobiology; 2009; 214(8):683-91. PubMed ID: 19249118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation.
    Hackstein H; Knoche A; Nockher A; Poeling J; Kubin T; Jurk M; Vollmer J; Bein G
    Cell Immunol; 2011; 271(2):401-12. PubMed ID: 21889130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BIRM 270: a novel inhibitor of arachidonate release that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.
    Farina PR; Graham AG; Hoffman AF; Watrous JM; Borgeat P; Nadeau M; Hansen G; Dinallo RM; Adams J; Miao CK
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1418-26. PubMed ID: 7996454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.
    Sisson JH; Prescott SM; McIntyre TM; Zimmerman GA
    J Immunol; 1987 Jun; 138(11):3918-26. PubMed ID: 3035016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of acetylshikonin, a natural naphthoquinone, on the production of leukotriene B4 and thromboxane A2 in rat neutrophils.
    Hsu MF; Chang LC; Huang LJ; Kuo SC; Lee HY; Lu MC; Wang JP
    Eur J Pharmacol; 2009 Apr; 607(1-3):234-43. PubMed ID: 19232341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene B4 biosynthesis in polymorphonuclear leukocytes from blood of umbilical cord, infants, children, and adults.
    Kikawa Y; Shigematsu Y; Sudo M
    Pediatr Res; 1986 May; 20(5):402-6. PubMed ID: 3012451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA recognition via TLR7 and TLR8.
    Hornung V; Barchet W; Schlee M; Hartmann G
    Handb Exp Pharmacol; 2008; (183):71-86. PubMed ID: 18071655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation.
    Larangé A; Antonios D; Pallardy M; Kerdine-Römer S
    J Leukoc Biol; 2009 Apr; 85(4):673-83. PubMed ID: 19164127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, characterization and genetic mapping of TLR7, TLR8a1 and TLR8a2 genes in rainbow trout (Oncorhynchus mykiss).
    Palti Y; Gahr SA; Purcell MK; Hadidi S; Rexroad CE; Wiens GD
    Dev Comp Immunol; 2010 Feb; 34(2):219-33. PubMed ID: 19825389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR7/8 ligand, R-848, inhibits IgE synthesis by acting directly on B lymphocytes.
    Shen E; Lu L; Wu C
    Scand J Immunol; 2008 Jun; 67(6):560-8. PubMed ID: 18397197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells.
    Smits EL; Cools N; Lion E; Van Camp K; Ponsaerts P; Berneman ZN; Van Tendeloo VF
    Cancer Immunol Immunother; 2010 Jan; 59(1):35-46. PubMed ID: 19449004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.